$CLS

MIONIS ROBERT sold $36.3M of CLS (indirect holdings)

MIONIS ROBERT (Chief Executive Officer) sold 98,453 indirectly-held shares of CELESTICA INC (CLS) at an average of $368.99 ($360.28–$374.16, $36.33M total) across 20 trades on 2026-08-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · MIONIS ROBERT
Published Aug 7, 2026, 12:19 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 12:32 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CLS
Neutral
medium confidence
Mentioned
$CLS
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CLSNeutralLow
01

Why it matters

Traders may briefly reassess sentiment around management confidence, but the 10b5-1 structure generally limits inference about near-term business outlook.

02

Market read

A large CEO share sale ($36.3M) is disclosed, but it is pre-arranged under 10b5-1, suggesting a modest and likely short-lived market impact.

03

What to watch

The filing notes indirect holdings and multiple small trades across a price band, which can make the sale less informative than a single, clearly timed discretionary transaction.

Relevance 6/10Novelty 4/10Timing: SEC Form 4 filed Aug 6, covering Aug 4 sales.

Background

The article is an SEC Form 4 insider transaction disclosure for Celestica (CLS) by CEO Mionis Robert, indicating an open-market sale under a Rule 10b5-1 plan.

Company-level read

Ticker impact

$CLSNeutralMedium confidence
Context

Celestica CEO Mionis Robert sold $36.3M of CLS shares via a 10b5-1 plan, disclosing 98,453 shares sold at $360.28–$374.16.

Expected impact

Likely limited, short-lived negative bias unless accompanied by other fundamental news.

Evidence & confidence

The filing is a primary SEC Form 4 disclosure with large dollar value, but it explicitly states a pre-arranged 10b5-1 plan, which typically dampens interpretive impact.

Market effects

Minimal, as this is company-specific insider activity without sector-wide policy or guidance changes.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect routine liquidity needs rather than a bearish view on fundamentals.

Key entities

  • CELESTICA INC

    Subject of the Form 4 insider transaction disclosure.

  • MIONIS ROBERT

    CEO and officer/director who sold shares via a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CLSMed

Canada Trade War: What It Means for Electronics Manufacturing · EMSNow

Canada and the US imposed tariffs on each other's exports, including electronics, with no expiry date. Canadian electronics exports are heavily dependent on the US, making the sector vulnerable. Celestica and other EMS providers may relocate production to mitigate costs. Provincial and federal governments are offering support programs. Investors should watch Q3 earnings for affected companies and the impact of Canada's retaliatory tariffs on September 8.

$CLSMedAI 8/10

Celestica Stock Falls 2.63%: Why TSX:CLS Is in Focus After AI Infrastructure Boom, $20.5 Billion Revenue Outlook and New 2027 Growth Catalysts

Celestica Inc. (TSX:CLS) shares fell 2.63% on Aug. 14, 2026 despite strong Q2 results and raised outlook. Q2 revenue rose about 62% to US$4.70B and adjusted EPS to US$2.54. 2026 revenue guidance was lifted to about US$20.5B, adjusted EPS to US$11.30, and FCF to US$600M, with 2027 growth expected to accelerate on AI infrastructure demand.